Physician profile
John Nesiba
NPI 1326277906
$2,413.09
in general payments reported to CMS, 2019-2025
13 companies · $795 in 2025
The $795 reported for 2025 was more than what 84% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $89.82 · 2021: $81.83 · 2022: $205 · 2023: $507 · 2024: $476 · 2025: $795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,158 · Food and Beverage: $489 · Entertainment: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,158.00 |
| Food and Beverage | $489.17 |
| Entertainment | $130.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,158.00 | 2024-2025 | |
| Nobel Biocare USA | $766.39 | 2019-2023 | Nobelactive |
| Keystone Dental INC. | $130.59 | 2023 | |
| Stryker Corporation | $127.07 | 2019-2021 | |
| Biohorizons Implant Systems INC. | $62.16 | 2025 | Biohorizons Dental Implants |
| Apyx Medical Corporation | $52.63 | 2019 | |
| Galderma Laboratories, L.P. | $21.43 | 2024 | |
| Ormco Corporation | $18.70 | 2023 | Creos Xenogain |
| Zimmer Biomet Holdings, INC. | $17.55 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $15.89 | 2021 | |
| Henry Schein, INC. | $15.34 | 2025 | Nuoss, Ace Surgical Supply, Allooss Allograft Putty |
| Boston Scientific Corporation | $14.13 | 2025 | General - Therapies |
| Geistlich Pharma, North America, INC. | $13.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Nesiba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.